AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kymera Therapeutics, Inc.

$126.63 +$53.87 (+74.04%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$122.60
Day Range
$117.31$127.12
Year Range
$55.66$130.05
Market Cap
10.81B
AVG Volume
823.52K
Trailing/Forward PE
-34.88/-
PEG ratio
-2.41
Dividend Yield
-
Next Earnings Date
2027-02-25
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
050M100M150M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
KYMR Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q3102.22M
26 Q2104.99M
26 Q151.47M
25 Q439.2M
25 Q343.73M
25 Q244.71M
25 Q158.88M
24 Q447.07M
24 Q387.56M
24 Q288.55M
Net Income (USD) · TTM
-400M-300M-200M-100M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
KYMR Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q3-349.47M
26 Q2-299.65M
26 Q1-315.05M
25 Q4-311.4M
25 Q3-295.12M
25 Q2-275.43M
25 Q1-240.88M
24 Q4-223.86M
24 Q3-167.47M
24 Q2-157.85M
Operating Income (USD) · TTM
-600M-400M-200M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
KYMR Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q3-404.89M
26 Q2-350.18M
26 Q1-359.13M
25 Q4-349.4M
25 Q3-332.26M
25 Q2-311.86M
25 Q1-278.23M
24 Q4-261.63M
24 Q3-200.19M
24 Q2-185.58M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: KYMR

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 25 Feb 2027.

Kymera Therapeutics, Inc.
KYMR
Stockpicker

Video analysis: KYMR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KYMR

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.